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Summary. Frailty models have a prominent place in survival analysis to model univariate and multivariate time-to-event
data, often complicated by the presence of diﬀerent types of censoring. In recent years, frailty modeling gained popularity in
infectious disease epidemiology to quantify unobserved heterogeneity using Type I interval-censored serological data or current
status data. In a multivariate setting, frailty models prove useful to assess the association between infection times related
to multiple distinct infections acquired by the same individual. In addition to dependence among individual infection times,
overdispersion can arise when the observed variability in the data exceeds the one implied by the model. In this article, we
discuss parametric overdispersed frailty models for time-to-event data under Type I interval-censoring, building upon the work
by Molenberghs et al. (2010) and Hens et al. (2009). The proposed methodology is illustrated using bivariate serological data on
hepatitis A and B from Flanders, Belgium anno 1993–1994. Furthermore, the relationship between individual heterogeneity and
overdispersion at a stratum-speciﬁc level is studied through simulations. Although it is important to account for overdispersion,
one should be cautious when modeling both individual heterogeneity and overdispersion based on current status data as model
selection is hampered by the loss of information due to censoring.
Key words: Correlated frailty models; Current status data; Gompertz hazards; Infectious disease epidemiology;
Overdispersed frailty models; Serological survey data.
1. Introduction
Frailty models are very popular in survival analysis due to
their convenient way of modeling unobserved heterogeneity.
In its simplest form, a frailty is a latent random propor-
tionality factor modifying the individual’s hazard function,
or the one of related individuals. Although the term “frailty”
was introduced by Vaupel et al. (1979) in a univariate set-
ting, the concept goes back to the early work of Greenwood
and Yule (1920) on “accident proneness.” Due to the seminal
work by Clayton (1978), frailty models were highly promoted
by their applicability to model multivariate survival data.
In general, frailty models extend the well-known Cox pro-
portional hazards model (Cox, 1972) by including random
frailty terms allowing for a heterogeneous study population.
All sampled individuals diﬀer in their propensity to experience
the event under consideration, and consequently have diﬀer-
ent event hazards. In many cases, unobserved heterogeneity
arises from the inability to measure all relevant covariate
information for which the event hazard needs to be adjusted.
Under the proportional hazards assumption, the frailty acts
multiplicatively on a baseline hazard function, deﬁning a
random-eﬀects model for time-to-event data. In a multivari-
ate context, the joint frailty distribution imposes a correlation
structure among event and individual-speciﬁc frailties, and
consequently implies a dependence between event times. To
that end, shared and correlated frailty models have been pro-
posed (see, e.g., Wienke, 2010).
In many contemporary statistical analyses, the outcome
of interest is the time to a speciﬁc event such as death,
occurrence of disease, or discharge from hospital. Such
time-to-event data are prominent in survival data, both in
univariate as well as multivariate settings in which hierarchi-
cal structures are often present. In addition to accounting for
data hierarchies, there exists a need to account for overdisper-
sion in many data applications (Hinde and Deme´trio, 1998a;
Molenberghs et al., 2010). Overdispersion arises when the
observed variability in the data exceeds the variation pre-
dicted by the model. In such situation, the proposed model
and its prescribed mean-variance link are too restrictive to
describe the data adequately. In practice, many diﬀerent
causes for overdispersion exist such as cluster sampling, corre-
lation among individual responses, and unobserved covariate
information. In general, there exist two groups of models
to account for overdispersion: (1) moment-based approaches
relying on more ﬂexible forms for the mean-variance relation-
ship, and (2) two-stage models for the response entailing a
distribution for one or more parameters of the response model.
The latter method leads to compound probability distribu-
tions for the response variable enabling, at least in theory,
full likelihood estimation of the model parameters. Broad
overviews of moment-based and full-distribution approaches
for dealing with overdispersion are provided by Hinde and
Deme´trio (1998a,b) in the context of generalized linear models
(Nelder and Wedderburn, 1972; McCullagh and Nelder, 1989).
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These authors mainly focus on random-eﬀects based solutions
to the problem of overdispersion including the beta-binomial
model for binomial data relying on beta-distributed random
eﬀects, and the negative-binomial model for Poisson counts
with the natural parameter following a gamma distribution.
In the last two decades, cross-sectional serological studies,
providing insight into population immunity and individual-
level past infection experience, have become quintessential
to inform infectious disease models. Serological data con-
sists of infection-speciﬁc antibody titre concentrations based
on which individuals are typically classiﬁed as seropositive
or seronegative, entailing so-called current status data. Indi-
vidual immunological statuses regarding multiple infections
aggregated by age at cross-sectional sampling time con-
stitute multinomial response values. As individuals diﬀer
in social contact behaviour, susceptibility to infection and
infectiousness upon infection, frailty models are of impor-
tance to quantify unobserved variability in the time to the
acquisition of infections. Furthermore, the use of bivariate
frailty models in infectious disease epidemiology was popu-
larized by the seminal work of Farrington et al. (2001) and
the work by Hens et al. (2009) on shared and correlated
frailty models, respectively, applied to serological data on
immunizing infections. Recently, several extensions have been
proposed focusing on, but not limited to, recurrent infection
processes (Abrams and Hens, 2015) and time-varying indi-
vidual heterogeneity (Farrington et al., 2012; Unkel et al.,
2014). In addition, the issue of extra-multinomial variation in
immunological response data, due to reasons diﬀerent from
individual variability in event hazards, is addressed by apply-
ing Dirichlet-multinomial models (Farrington et al., 2013),
extending the well-known beta-binomial model for overdis-
persed binomial data. The approach undertaken in this article
diﬀers from the aforementioned one in the sense that random
eﬀects are introduced at the level of the baseline hazard rather
than assuming randomness directly at the probability scale
(i.e., by means of the Dirichlet distribution). In essence, our
approach extends the work by Molenberghs et al. (2010) to
the case of current status data. These authors introduced a
general and ﬂexible framework of generalized linear models
accounting for both overdispersion and clustering in case of
repeated measurements through the use of two separate sets of
random eﬀects, and with particular attention given to binary,
count and time-to-event data. Particular emphasis is placed
on so-called conjugate random eﬀects at the level of the mean
for overdispersion, and normal random eﬀects embedded in
the linear predictor for clustering (Molenberghs et al., 2007,
2014). We focus on parametric frailty models, implying the
speciﬁcation of a parametric shape for the baseline hazards.
The article is organized as follows. In Section 2, a motivat-
ing example is presented. The methodology is introduced in
Section 3, and maximum likelihood (ML) estimation is dis-
cussed in Section 4. The proposed frailty models are ﬁtted
to hepatitis A and B serology for which results are shown
in Section 5. Results of an additional data application are
brieﬂy discussed therein as well. In Section 6, a simulation
study is performed to assess model performance and eﬀects of
estimating both individual heterogeneity and overdispersion.
The manuscript ends with a discussion on the implications
of modeling multivariate current status data using overdis-
persed frailty models thereby highlighting avenues for further
research.
2. Case Studies
Bivariate cross-sectional serology consists of blood serum
samples tested for the presence of infection-speciﬁc IgG anti-
bodies, reﬂecting former infection experience. Blood samples
are tested using an enzyme-linked immunosorbent assay test,
classifying samples (and equivalently individuals) as either
being seropositive or seronegative based on a pre-speciﬁed
cut-oﬀ value. Hence, the individual’s serological status is a
direct measure of his/her immunity against the disease, at
least if complete serological protection is agreed upon. Since
the true infection (event) times are unobserved, and infec-
tion takes place either between birth and the observation
time for seropositives or thereafter for seronegatives, one is
faced with current status data. Hepatitis A and B serological
survey data, obtained from a sero-epidemiological study con-
ducted in 1993–1994 in Flanders, Belgium, is used to illustrate
the methodology. Hepatitis A is a viral infection of the liver
for which symptoms are diarrhoea, nausea, fever, abdominal
pain, and a yellow skin, and is mainly transmitted via contam-
inated food or water. Hepatitis B causes liver inﬂammation,
jaundice and in rare cases death Transmission is mainly driven
by sexual and blood contact. In total, 4026 blood samples were
drawn from a representative study population, and tested
for the presence of hepatitis A and B antibodies. Complete
immunological information on hepatitis A and B antibody
prevalence was obtained for 3787 subjects, and age at the time
of data collection was registered for each of these study sub-
jects. For more details, the reader is referred to Beutels et al.
(1997). Furthermore, mumps and rubella serological survey
data, obtained from a large survey of prevalence of infection-
speciﬁc antibodies conducted between November 1986 and
December 1987 in the UK, are considered as a second data
application (see Morgan-Capner et al., 1988 for more details).
3. Materials and Methods
3.1. Terminology
Time-to-event data represent the times to a speciﬁc event
such as death, failure, or infection. The analysis of such data
is often hampered by the occurrence of censoring, implying
that response values are only partially known. Right-censored
observations occur when true event times exceed the follow-up
period of individuals, for example, as a result of subjects drop-
ping out before the end of the study or the study ending prior
to the occurrence of the event. In order to exemplify right
censoring in a bivariate setting with clustering, let T ∗ijk repre-
sent the true event time, Cijk the censoring time and ijk =
1T ∗
ijk
≤Cijk the censoring indicator for event i = 1, 2 and individ-
ual j = 1, . . . , Nk in stratum k = 1, . . . , K. In case of right
censoring, the observation times Tijk are equal to the true event
times T ∗ijk only when events occur prior to censoring, that is,
T ∗ijk ≤ Cijk, and Tijk equals Cijk otherwise. In general, right cen-
soring can be considered as a special case of interval censoring,
for which T ∗ijk is known to take place in some time window,
with time intervals [Cijk,∞). Finally, in case of current sta-
tus data, the true event times are unknown, hence Tijk = Cijk,
for all sampled individuals and both events. The censoring
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indicator ijk represents event experience before Tijk, or event
status, hence the name current status data. Throughout the
article, all derivations are made under the general assump-
tion of clustering into strata, that is, each subject is classiﬁed
into one of the K strata, and the problem of overdispersion
is discussed at the subject as well as stratum level. Note that
we adopt the term “stratum” throughout this article, inspired
by our data application (i.e., age cohorts), although “cluster”
can be used instead in case of hierarchical data.
3.2. Generalized Linear Models
Let T ∗ijk represent the time to event i for individual j in stra-
tum k, ignoring censoring for the time being. The random
variable T ∗ijk follows an exponential family distribution, that
is, a member of the class of distribution functions used in a
generalized linear model (McCullagh and Nelder, 1989), if the
probability density function can be written as
fi(t
∗
ijk|ηi, φi) = exp
[
φ−1i
{
t∗ijkηi − ψi(ηi)
}+ ci(t∗ijk, φi)] , (1)
where ηi and φi represent a speciﬁc set of unknown parame-
ters, and ψi(·) and ci(·, ·) are known functions. The parameter
ηi is termed natural or canonical parameter whereas φi
denotes the dispersion parameter. The mean μi and variance
σ2i of the random variable T
∗
ijk follow from the function ψi(·)
through E(T ∗ijk) = μi = ψ
′
i(ηi) and Var(T
∗
ijk) = σ
2
i = φiψ
′′
i (ηi)
(Molenberghs and Verbeke, 2005). In general, the mean and
variance are related through σ2i = φiψ
′′
i {ψ′−1i (μi)} = φivi(μi),
with vi(·) the so-called variance function corresponding to
event i. The variance function describes the mean-variance
relationship.
For time-to-event data, the exponential and Weibull
distributions are often considered in literature for non-
negative response variables (see, e.g., Molenberghs et al.,
2010; Wienke, 2010). A ﬂexible alternative to these dis-
tributions is the Gompertz distribution encompassing
both monotonic increasing and decreasing hazards. The
Gompertz distribution has been used by Hens et al. (2009)
to analyse the serological data introduced in Section 2. The
Gompertz model T ∗ijk ∼ G (ξi, νi) can be formulated as follows:
fi(t
∗
ijk) = ξi exp
(
νit
∗
ijk
)
exp
[
− ξi
νi
{
exp
(
νit
∗
ijk
)− 1}] , (2)
where ξi > 0 and −∞ < νi < ∞ are unknown model param-
eters. Although the Weibull and Gompertz distributions are
not part of the exponential family in the conventional fashion,
they do belong to the family in a contrived way by con-
sidering transformations of the variable T ∗ijk. In case of the
Gompertz model, one can easily show that the random vari-
able ν−1i {exp(νiT ∗ijk) − 1} follows an exponential distribution
with parameter ξi. Although we focus in the main text on the
Gompertz model, expressions corresponding to the exponen-
tial and Weibull models can be found in Web Appendix A.
Covariate information xijk for individual j in stratum k
can be accounted for by means of the proportional hazards
assumption (Cox, 1972): T ∗ijk|xijk ∼ G (ξiκijk, νi), where κijk =
exp(x′ijkζi), xijk is a p-dimensional vector of known covariate
values, and ζi is a p-dimensional vector of unknown ﬁxed-
eﬀects parameters.
3.3. Overdispersion Models
One elegant route to accommodate overdispersion is by means
of a two-stage approach specifying a latent distribution for one
of the model parameters. In general, this approach consists of
choosing a conditional distribution for the outcome T ∗ijk, given
an event-speciﬁc random eﬀect θijk for subject j in stratum
k and covariate information xijk, denoted by fi(t
∗
ijk|θijk, xijk),
and combined with a distributional model for the random
eﬀect, that is, fi(θijk). Doing so, the marginal model of the
outcome T ∗ijk|xijk, assuming independence of the random eﬀects
θijk and xijk, and suppressing dependence on model parameters
becomes:
fi(t
∗
ijk|xijk) =
∫
R
fi(t
∗
ijk|θijk, xijk)fi(θijk)dθijk, (3)
where R represents the range of the overdispersion random
variable θijk. For the Gompertz setting described previously,
the random eﬀect θijk can be introduced as T
∗
ijk|θijk, xijk ∼
G (ξiθijkκijk, νi), for θijk a non-negative random variable:
fi(t
∗
ijk|θijk, xijk) = ξiθijkκijk exp
(
νit
∗
ijk
)
× exp
[
− ξiθijkκijk
νi
{
exp
(
νit
∗
ijk
)− 1}] . (4)
More speciﬁcally, the model formulation implies a propor-
tional hazards assumption (see, e.g., Cox, 1972):
λi(t
∗
ijk|θijk, xijk) =
fi(t
∗
ijk|θijk, xijk)
Si(t
∗
ijk|θijk, xijk)
= ξiθijkκijk exp
(
νit
∗
ijk
)
, (5)
where θijk and κijk act multiplicatively on the baseline haz-
ard function λi0(t
∗
ijk) = ξi exp(νit∗ijk), and Si(t∗ijk|θijk, xijk) = 1 −
Fi(t
∗
ijk|θijk, xijk) is the conditional event-speciﬁc survival func-
tion. The derivation of the conditional survival function is
presented in Web Appendix A.
Various random-eﬀects distributions with density fi(θijk)
can be considered. The gamma distribution is a popular choice
in survival analysis since it is in line with the data range, giv-
ing rise to a Gompertz-gamma model. Furthermore, gamma
random eﬀects can be motivated by the concept of conju-
gacy (Cox and Hinkley, 1974; Lee et al., 2006) exploited in
Molenberghs et al. (2010) in the context of repeated mea-
surements. However, this approach is not limited to the
use of gamma random eﬀects and other non-negative distri-
butions such as the inverse Gaussian distribution produce
tractable expressions for the marginal densities fi(t
∗
ijk|xijk)
and marginal survival functions Si(t
∗
ijk|xijk). In Table 1, the
model components for the Gompertz-gamma and Gompertz-
inverse Gaussian models are summarized in terms of the
Gompertz hazard λi0(t
∗
ijk) and integrated or cumulative Gom-
pertz hazard i0(t
∗
ijk) = (ξi/νi){exp(νit∗ijk) − 1}. Note that the
expressions for the unconditional survival functions coin-
cide with the evaluation of the Laplace transform of θijk in
κijki0(t
∗
ijk), i.e., Si(t
∗
ijk|xijk) = Lθijk {κijki0(t∗ijk)}. The Gompertz-
gamma and Gompertz-inverse Gaussian models presented in
Table 1 deﬁne gamma and inverse Gaussian frailty mod-
els, respectively, with Gompertz baseline hazard functions
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Table 1
Model elements for the Gompertz-gamma and Gompertz-inverse Gaussian models.
Gompertz-gamma Gompertz-inverse Gaussian
Element θijk ∼  (αi, βi) θijk ∼ IG (αi, βi)
fi(θijk)
θ
αi−1
ijk exp (θijk/βi)
β
αi
i  (αi)
√
αi
2πθ3ijk
exp
[
− αi
2β2i θijk
(θijk − βi)2
]
fi(t
∗
ijk|xijk)
λi0(t
∗
ijk)κijkαiβi[
1 + βiκijki0(t∗ijk)
]αi+1
νiλi0(t
∗
ijk) exp
{
αi
βi
[
1 −
√
1 + 2β2i α−1i κijki0(t∗ijk)
]}
κijkαiβi√
1 + 2β2i α−1i κijki0(t∗ijk)
Si(t
∗
ijk|xijk)
1[
1 + βiκijki0(t∗ijk)
]αi exp
{
αi
βi
[
1 −
√
1 + 2β2i α−1i κijki0(t∗ijk)
]}
(Wienke, 2010). The event-speciﬁc random eﬀects θijk, i = 1,
2, are termed individual frailties and can be assumed (1) inde-
pendent (univariate frailty model); (2) equal θ1jk = θ2jk = θjk
(shared frailty model); or (3) correlated (correlated frailty
model), requiring the speciﬁcation of a bivariate frailty distri-
bution for θjk = (θ1jk, θ2jk)
′. One way to deﬁne a correlation
structure among frailties θ1jk and θ2jk is by means of the
“variable-in-common” method; θijk = σ
2
θi
(W0jk + Wijk), where
the components Wcjk are independent random variables with
mean and variance ωc, c = 0, 1, 2. In survival analysis, it
is customary to set the mean of the frailties θijk equal to
one for reasons of identiﬁability. Therefore, αiβi = 1 or βi
= 1 for gamma or inverse Gaussian random eﬀects, respec-
tively, leading to frailty variances Var (θijk) = σ
2
θi
= α−1i . In
the correlated frailty setting (3) with additive decomposi-
tion, this identiﬁability constraint implies frailty variances
Var(θijk) = σ
2
θi
= 1/ (ω0 + ωi), and non-negative correlation
ρθ = ω0/
√
(ω0 + ω1) (ω0 + ω2). The correlation is bounded
above by the minimum of the ratios of the frailty standard
deviations, namely, 0 ≤ ρθ ≤ min
(
σθ1
σθ2
,
σθ2
σθ1
)
. As the event-
speciﬁc random eﬀects describe both the between-subject
variability as well as the association between event-speciﬁc
event times, ρθ and the random-eﬀects variances are depen-
dent. In the remainder of this article, the variance-covariance
matrix associated with the random vector θjk is denoted by
θ. Although dependence between event times within the
same individual is imposed by means of the speciﬁed covari-
ance structure, the model formulation in equation (5) implies
independence among event times of diﬀerent individuals,
irrespective of the stratum to which they belong. There-
fore, overdispersion at the stratum-level is not yet accounted
for. Hereunder, two diﬀerent methods are considered
to do so.
3.3.1. Dirichlet-multinomial model. First of all, we con-
sider the Dirichlet-multinomial (DM) model to accommodate
for extra-multinomial variability at the stratum level. This
model has been considered before by Farrington et al. (2013)
for the analysis of bivariate serological data. In order to intro-
duce this marginal model, we consider bivariate current status
data (δ1jk, δ2jk, t1jk, t2jk), where δijk and tijk are the observed sta-
tus and observation times regarding event i = 1, 2 for subject
j = 1, . . . , Nk in stratum k = 1, . . . , K, respectively. Let nlmk
denote the number of subjects in stratum k having status l
and m (l, m = 0, 1) for event 1 and 2, respectively. Therefore,
the data comprise 4-tuples nk = (n00k, n10k, n01k, n11k) with
expected proportions pk = (p00k, p10k, p01k, p11k) in the four
cells. The DM model can be used to account for overdisper-
sion at the stratum-level, thereby hypothesizing a mixture
distribution directly on the probability scale:
nk|πk ∼ Multinomial (Nk,πk),
πk ∼ Dirichlet (ϕpk) ,
resulting in a compound distribution with Dirichlet param-
eters ϕpk = (ϕplmk)l,m > 0, and the marginal density function
for nk given by:
f (nk|pk, ϕ) = CNknlmk
 (ϕ)
 (Nk + ϕ)
∏1
l,m=0  (nlmk + ϕplmk)∏1
l,m=0  (ϕplmk)
, (6)
where Nk =
∑1
l,m=0 nlmk and C
Nk
nlmk
= Nk!/
∏1
l,m=0 nlmk! the nor-
malizing constant. When individual contributions to nlmk are
independent, the DM model reduces to a multinomial one
for the response vector nk. However, extra-multinomial vari-
ation is introduced using the overdispersion parameter ϕ > 0
implying correlation ρ =
√
1/ (1 + ϕ) among individual multi-
nomial responses within the same stratum (0 < ρ < 1).
Suppose that, in an infectious disease context with K age
strata, serum samples of Nk individuals of age tk are avail-
able, for k = 1, . . . , K. Furthermore, let nlmk represent the
number of individuals of age tk with status l and m with
respect to infection 1 and 2, respectively. Consequently, the
expected proportions in the four cells are given by the popula-
tion survival functions derived from the overdispersed frailty
model formulated in equation (5). We will come back to this
in Section 4.
3.3.2. Multiplicative overdispersed frailty models. Since
individuals of the same stratum are likely to be correlated, the
model presented in equation (5) can be extended to incorpo-
rate additional stratum-speciﬁc random eﬀects υik for subjects
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in stratum k = 1, . . . , K and event i = 1, 2. These random
eﬀects can be introduced at the level of the hazard, implying:
λi(t
∗
ijk|θijk, υik, xijk) = ξiθijkυikκijk exp
(
νit
∗
ijk
)
, (7)
fi(t
∗
ijk|θijk, υik, xijk) = θijkυikκijkλi0(t∗ijk) exp
[−θijkυikκijki0(t∗ijk)] ,
again suppressing dependence on model parameters associ-
ated with the baseline hazard function λi0(t
∗
ijk), the frailty
distribution fi(θijk) and the covariate model κijk. The ran-
dom vector υk = (υ1k, υ2k)
′ has mean vector 1, to ensure
identiﬁability, and variance-covariance matrix υ:
υ =
(
σ2υ1 ρυσυ1συ2
ρυσυ1συ2 σ
2
υ2
)
.
Outcomes for event i from subjects in the same stratum
are therefore correlated through υik while observations from
diﬀerent strata are assumed independent. Although it is not
strictly necessary, the two sets of random eﬀects θjk and
υk are assumed to be independent. Distributional assump-
tions for θjk and υk produce a marginal model fi(t
∗
ijk|xijk).
In the next section, the methodology is cast into the ML
framework.
4. Maximum Likelihood Estimation
Fitting the overdispersed frailty model in equation (7) to
bivariate uncensored time-to-event data t∗jk = (t
∗
1jk, t
∗
2jk, xijk)
proceeds by integrating over the latent random eﬀects, or
frailties, resulting in the following likelihood contribution for
stratum k:
Lk(ϑ,θ,υ|t∗jk, xjk) =
∫
R
Nk∏
j=1
f12(t
∗
jk|ϑ, θjk,υk, xijk)
× f (θjk|θ)f (υk|υ)dθjkdυk,
wheref12(t
∗
jk|ϑ, θjk,υk, xjk)=f1(t∗1jk|ϑ1, θ1jk, υ1k, x1jk)f2(t∗2jk|ϑ2,
θ2jk, υ2k, x2jk) under the assumption of conditional indepen-
dence of the event times T ∗1jk and T
∗
2jk given the random
frailties, and ϑi the vector of infection-speciﬁc baseline
hazard parameters ξi and νi, and regression parameters ζi.
Under model (4), the likelihood contribution for stratum k
simpliﬁes to the product of individual contributions
Ljk(ϑ,θ|t∗jk, xjk) =
∫
R
f1(t
∗
1jk|ϑ1, θ1jk, x1jk)
× f2(t∗2jk|ϑ2, θ2jk, x2jk)f (θjk|θ) dθjk,
which corresponds to assuming a degenerate distribution for
the random vector υk at 1. In general, the likelihood function
becomes
L
(
ϑ,θ,υ|t∗jk, xjk
) = K∏
k=1
Lk(ϑ,θ,υ|t∗jk, xjk). (8)
Maximizing the likelihood in (8) is complicated due to the
presence of K integrals. Partial marginalization can be con-
sidered to overcome the direct maximization problem, in
agreement with Molenberghs et al. (2010), thereby integrating
out one set of random eﬀects.
Partial marginalization is performed by integrating the
conditional density fi(t
∗
ijk|ϑi, θijk, υik, xijk) over the frailty dis-
tribution fi(θijk), leaving the frailty term υik untouched.
Integrating over θijk yields
fi(t
∗
ijk|ϑi, υik, xijk) = −
d
dt
Si(t|ϑi, υik, xijk)
∣∣∣∣
t=t∗
ijk
= − d
dt
Lθijk [υikκijki0(t)]
∣∣∣∣
t=t∗
ijk
(9)
in terms of the survival function Si(·), or the Laplace trans-
form Lθijk (·) with respect to θijk. Closed-form expressions
for the Laplace transform are available for gamma and
inverse Gaussian random variables θijk (see Section 3.3 and
Web Appendix B):
Lθij (s) = (1 + βis)−αi ,
Lθij (s) = exp
{
αi
βi
(
1 −
√
1 + 2β
2
i s
αi
)}
,
respectively. The product of univariate density functions
fi(t
∗
ijk|ϑi, υik, xijk) produces the joint density f12(t∗jk|ϑ,υk, xjk)
in the univariate frailty context, thereby assuming indepen-
dence between θ1jk and θ2jk. In general, deriving the joint
density function, conditional on random eﬀects υik, involves
integration over the joint density f (θjk|θ), and can be
expressed in terms of the joint Laplace transform. Expressions
for the partially marginalized univariate and joint density
functions under diﬀerent distributional assumptions for θijk
are presented in Web Appendix B. The principle of partial
marginalization is useful to lower the dimensionality of inte-
gration when integrating out random eﬀects numerically, and
applies when strong conjugacy holds (see, e.g., Molenberghs
et al., 2014).
Since we are faced with current status data, the likelihood
function requires modiﬁcation. Therefore, consider bivariate
cross-sectional serological data (δ1jk, δ2jk, t1jk, t2jk) with δijk
and tijk as previously deﬁned, and univariate observation
times t1jk = t2jk ≡ tjk for both events. In our application,
strata are deﬁned based on age cohorts such that all sub-
jects within the same stratum are observed at the same
time, that is, t1k = . . . = tNkk ≡ tk. The random vector nk =
(n00k, n10k, n01k, n11k), where nlmk represents the number
of subjects in stratum k with status l and m with regard
to event 1 and 2, respectively, follows a multinomial dis-
tribution, conditional on observation time Tijk = tk, with
probability vector pk = p(tk) = (plm (tk|ϑ,θ,υ))l,m=0,1;
plmk = plm (tk|ϑ,θ,υ) = Pr (1jk = l, 2jk = m | ϑ,θ,υ).
The stratum-speciﬁc multinomial contribution of bivariate
aggregated current status data (nk, tk) to the likelihood is
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given by:
Lk (nk, tk) = CNknlmk
1∏
l,m=0
p
nlmk
lmk ,
suppressing dependence on the model parameters ϑ, θ
and υ for the sake of simplicity. The multinomial prob-
abilities plmk can be expressed in terms of the marginal
univariate and joint survival functions as follows: p11k =
1 − S1(tk) − S2(tk) + S12(tk, tk), p10k = S2(tk) − S12(tk, tk), p01k
= S1(tk) − S12(tk, tk), p00k = S12(tk, tk), where marginal sur-
vival functions are obtained after integrating out the frailties,
and derivation of the joint survival function relies on the
conditional independence assumption. The likelihood contri-
bution for aggregated age-group data nk in group k in the DM
model equals f (nk|pk, ϕ) in equation (6). In both cases, the
likelihood functions are constructed by taking the product of
contributions Lk, k = 1, . . . , K.
5. Data Applications
5.1. Hepatitis A and B, Flanders, Belgium
In this section, the methodology is illustrated on hepatitis A
and B serological data from Flanders, Belgium, anno 1993–
1994 for which the baseline hazard can plausibly be assumed
to be of the Gompertz type (Web Appendix C). The event
times of interest T ∗ijk are infection times with regard to hepati-
tis A (i = 1) and hepatitis B (i = 2). Univariate observation
times Tjk and censoring indicators ijk refer to the age at the
time of data collection and the immunological status, respec-
tively, for individual j = 1, . . . , Nk in age-group (stratum) k.
Age strata of length one are considered in the analyses giving
rise to a total of K = 95 strata. Stratiﬁcation in age cohorts
is a natural one since behavioural and/or environmental con-
ditions with respect to the acquisition of infections could
vary across age cohorts, for example, overdispersion resulting
from test variability (Unkel et al., 2014). Individual covariate
information is absent in our data application, thereby exclud-
ing κijk from the general model formulations in equations
(6) and (7). The models are ﬁtted using the SAS procedure
NLMIXED. All SAS code is made available on the I-BioStat
website (https://ibiostat.be/online-resources/).
5.1.1. Overdispersed frailty models. In Table 2, an
overview of the overdispersed frailty models (with Gompertz
baseline hazards) is presented with distributional assumptions
regarding infection- and individual-speciﬁc frailties θijk and
stratum-speciﬁc random eﬀects υik. Traditional frailty models
result from assuming a degenerate distribution at 1 for υk.
Alternatively, lognormal random eﬀects υk with mean vector
1 and variance-covariance matrix υ are considered to accom-
modate extra-multinomial variability at the age-group level.
Note that the speciﬁcation of lognormal random eﬀects υik is
equivalent to deﬁning a random vector bk ∼ N2(μb,b) with
υik = exp(bik) and μb =
(
0.5σ2b1 , 0.5σ
2
b2
)′
ensuring that E(υik)
= 1. Furthermore, the variance-covariance matrix b takes
the form:
b =
(
log(σ2υ1 + 1) log(ρυσυ1συ2 + 1)
log(ρυσυ1συ2 + 1) log(σ2υ2 + 1)
)
.
Recall that the frailty variances are related to the parameters
αi through σ
2
θi
= 1/αi.
In Table 3, ML estimates for the model parameters in
the shared and correlated Gompertz-gamma and -inverse
Gaussian frailty models are shown together with AIC- and
BIC-values (upper part). The correlated gamma frailty model
outperforms all other ﬁtted models based on both information
criteria, implying a correlation between individual infection
times which diﬀers from unity (shared frailty model). Despite
the fact that the data favours a model accounting for cor-
relation among event times (ρθ = 0), results from univariate
Gompertz-gamma and -inverse Gaussian frailty models are
provided in Web Appendix C.
Table 2
Distributional assumptions with regard to θjk and υk in the overdispersed frailty models described in equation (7).
υik
θijk υk = 1 υk ∼ logN2 (1,υ)
(1) independence
θijk ∼ 
(
αi, α
−1
i
)
univariate gamma univariate
gamma-lognormal
θijk ∼ IG (αi, 1) univariate inverse Gaussian univariate
inverse Gaussian-lognormal
(2) shared
θjk ∼  (α, α−1) shared gamma shared
gamma-lognormal
θjk ∼ IG (α, 1) shared inverse Gaussian shared
inverse Gaussian-lognormal
(3) correlated
θjk ∼ 2 (1,θ) correlated gamma correlated
gamma-lognormal
θjk ∼ IG2 (1,θ) correlated inverse Gaussian correlated
inverse Gaussian-lognormal
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Table 3
Estimates and standard errors between brackets for shared and correlated Gompertz-gamma and Gompertz-inverse Gaussian
frailty models (upper part), univariate, shared and correlated Gompertz-gamma-lognormal frailty models (middle part) and
Dirichlet-multinomial Gompertz-gamma frailty models (lower part) applied to bivariate serology on hepatitis A and B from
Flanders, Belgium.
Gompertz frailty models
Shared Correlated
Parameter Gamma Inverse Gaussian Gamma Inverse Gaussian
ξ1 × 102 1.219 (0.103) 1.346 (0.096) 0.668 (0.115) 1.363 (0.113)
ν1 × 102 3.693 (0.461) 3.278 (0.367) 10.481 (1.686) 3.934 (0.588)
ξ2 × 102 0.172 (0.034) 0.173 (0.034) 0.178 (0.036) 0.175 (0.035)
ν2 × 102 −0.023 (0.741) −0.032 (0.745) 0.111 (0.930) 0.002 (1.241)
σθ1 0.723 (0.084) 0.800 (0.133) 1.635 (0.175) 1.108 (0.281)
σθ2 0.723 (0.084) 0.800 (0.133) 1.417 (1.167) 1.016 (2.849)
ρθ 1.000 (−) 1.000 (−) 0.557 (0.457) 0.763 (2.060)
−2 log (L) 5687.020 5690.547 5653.495 5688.325
AIC 5697.020 5700.547 5667.495 5702.325
BIC 5709.789 5713.317 5685.372 5720.202
Gompertz-gamma-lognormal frailty models
Correlated
Parameter Univariate Shared Unrestricted συ1 = συ2
ξ1 × 102 0.785 (0.137) 1.272 (0.115) 0.633 (0.147) 0.612 (0.142)
ν1 × 102 8.709 (1.819) 3.484 (0.478) 12.730 (3.298) 13.588 (2.618)
ξ2 × 102 0.165 (0.041) 0.168 (0.036) 0.163 (0.036) 0.163 (0.036)
ν2 × 102 1.464 (3.540) 0.314 (0.766) 0.600 (0.874) 0.632 (0.876)
σθ1 1.447 (0.210) 0.715 (0.087) 1.867 (0.300) 1.944 (0.226)
σθ2 2.544 (3.461) 0.715 (0.087) 1.356 (0.629) 1.431 (0.613)
ρθ 0.000 (−) 1.000 (−) 0.677 (0.297) 0.664 (0.268)
συ1 0.122 (0.197) 0.147 (0.062) 0.346 (0.223) 0.415 (0.114)
συ2 0.529 (0.427) 0.400 (0.107) 0.426 (0.123) 0.415 (0.114)
ρυ −0.590 (1.063) −0.671 (0.432) −0.626 (0.464) −0.595 (0.413)
−2 log (L) 5674.394 5672.675 5641.146 5641.252
AIC 5692.394 5688.675 5661.146 5659.252
BIC 5715.379 5709.106 5686.685 5682.237
Dirichlet-multinomial Gompertz-gamma frailty models
Parameter Univariate Shared Correlated
ξ1 × 102 0.766 (0.156) 1.286 (0.124) 0.655 (0.134)
ν1 × 102 9.013 (2.007) 3.282 (0.532) 10.918 (2.059)
ξ2 × 102 0.158 (0.035) 0.163 (0.036) 0.169 (0.037)
ν2 × 102 0.398 (4.077) 0.254 (0.783) 0.294 (0.908)
σθ1 1.503 (0.222) 0.678 (0.102) 1.698 (0.208)
σθ2 0.959 (12.515) 0.678 (0.102) 1.277 (1.066)
ρθ 0.000 (−) 1.000 (−) 0.611 (0.507)
ρ 0.093 (0.016) 0.092 (0.017) 0.078 (0.017)
−2 log (L) 5664.659 5672.014 5644.114
AIC 5678.659 5684.014 5660.114
BIC 5696.536 5699.337 5680.546
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Figure 1. Predicted multinomial probabilities pk = (p00k, p10k, p01k, p11k) (solid lines) corresponding to the correlated
Gompertz-gamma-lognormal frailty model and observed proportions (black circles) based on the hepatitis A and B serology
with size proportional to the number of observations in each age group.
Models combining individual and stratum-speciﬁc random
eﬀects are presented in the middle part of Table 3. Gompertz-
gamma-lognormal frailty models clearly perform better than
the traditional frailty models, indicating that overdispersion
at the group-level exists. Again, the combined model with
correlated individual-level random eﬀects θijk, either unre-
stricted or constrained with συ1 = συ2 , yields a better ﬁt
to the serological data as compared to univariate and
shared alternatives. Based on AIC- and BIC-values, the
analysis corresponding to the constrained correlated gamma-
lognormal model can be viewed as the ﬁnal one. Although
inverse Gaussian-lognormal models have been considered,
these models did not outperform the gamma-lognormal coun-
terparts, and results therefrom are therefore displayed in
Web Appendix C. The model ﬁt of the best model based
on AIC- and BIC-values is graphically depicted in Fig-
ure 1, displaying the model-based multinomial probabilities
pk = (p00k, p10k, p01k, p11k) together with the observed pro-
portions. The added value of this analysis compared to the
previous one reported by Hens et al. (2009) is a more reli-
able assessment of the amount of unobserved heterogeneity,
which is quintessential for the estimation of epidemiological
parameters. Furthermore, Hens et al. (2009) did not discuss
the implications of heterogeneity on the estimation of these
parameters. In Web Appendix C, we illustrate the estimation
of the (basic) reproduction number and critical vaccination
coverage, two commonly used epidemiological measures to
describe a pathogens transmission potential and the eﬀort
required to avoid outbreaks by means of vaccination, respec-
tively, in the presence of individual heterogeneity. Ignoring
such heterogeneity leads to a substantial underestimation of
both quantities. On top of that, an appreciable diﬀerence
was found between estimates derived from models with and
without accounting for overdispersion thereby underlining the
importance of modeling overdispersion.
5.1.2. Dirichlet-multinomial models. We ﬁt the DM
Gompertz-gamma models introduced in Section 3.3 to the
hepatitis A and B serology. These models diﬀer from the
Gompertz-gamma-lognormal models in the sense that they
introduce randomness directly on the multinomial probabil-
ity scale. Larger values for the overdispersion parameter ρ,
or equivalently smaller values for ϕ, imply more evidence in
favour of a model allowing for overdispersion compared to
the multinomial model. The correlated frailty model outper-
forms all other DM models (see lower part of Table 3) and
model ﬁt is almost equivalent to the one for the less parsi-
monious correlated Gompertz-gamma-lognormal model (see
middle part of Table 3). In conclusion, it seems sensible to
account for overdispersion when modeling the serology under
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study, albeit that equivalent overdispersed frailty models in
terms of model ﬁt provide diﬀerent heterogeneity estimates. In
Section 6, a simulation approach is used to assess performance
of the described methodology in light of these ﬁndings.
5.2. Rubella and Mumps, UK
In Web Appendix D, we illustrate the application of the pro-
posed models to serological data on mumps and rubella in
the UK, anno 1986–1987 (Farrington et al., 2001). In gen-
eral, the novel overdispersed frailty models outperform the
traditional shared and correlated ones. Our results are in line
with those reported by Farrington et al. (2001) in terms of
the marginal forces of infection and common transmission
route for mumps and rubella. However, the current analysis
extends the aforementioned one by combining both overdis-
persion and the inclusion of individual-speciﬁc frailty terms
thereby capturing the dependence between the two infections
as well as accounting for individual heterogeneity. Further-
more, the novel models are more ﬂexible compared to the DM
shared gamma frailty model, both in terms of the overdis-
persion process as well as the correlation structure for the
individual-speciﬁc frailty terms.
6. Simulation Study
In this simulation study, we aim at evaluating the performance
of the Gompertz-gamma-lognormal model in case of current
status data. We mainly focus on the estimation of the het-
erogeneity parameters and quantify the impact of diﬀerent
model assumptions thereon. The simulation setup was car-
ried out under diﬀerent scenarios, enabling the investigation
of the eﬀects of censoring, implications when jointly estimat-
ing heterogeneity and overdispersion, and eﬀects of sample
size and parametric baseline hazards. For an overview of the
simulation steps and details concerning the general simula-
tion protocol, we refer to Web Appendix E. In the simulation
approach presented in this article, Gompertz baseline hazards
(λi0(t) = ξi exp(νit)) are considered. Simulation results iden-
tifying the impact of sample size and information loss due
to censoring are presented in Web Appendix E. In addition,
performance of the models in case of exponential event times,
implying baseline hazards λi0(t) = λi0, is discussed there as
well.
6.1. Misspeciﬁcation of Overdispersion Process
In this section, misspeciﬁcation of the overdispersion process
at the stratum-level is studied. We relied on the correlated
gamma-lognormal model to generate current status data, and
investigated the performance of the correlated gamma and
Dirichlet-multinomial correlated gamma frailty models. Alter-
natively, one can assess the performance of the correlated
gamma-lognormal model when simulating data under the DM
model. The latter approach is undertaken in Web Appendix E.
Table 4 shows the true values, mean parameter estimates
(Mean), relative bias (Rel. Bias) and empirical standard error
(Emp. s.e.) estimates, convergence rate (CR), and AIC and
BIC-selection percentages (AIC % and BIC %) for current sta-
tus data under the Gompertz-gamma-lognormal model (based
on 500 runs). The choice of the Gompertz parameters, hetero-
geneity parameters and sample size N = 3787 are inspired by
the hepatitis A and B case study, entailing multisera data
which typically has a rather large sample size. Estimates
for the heterogeneity parameters are biased when ignoring
the extra-multinomial variation at the age-group level (i.e.,
in the correlated gamma model). Both within- as well as
between-stratum dependence among bivariate event times
are estimated using simulation-based Kendall’s τ estimates,
denoted by τˆWS and τˆBS , respectively (see Web Appendix E).
Based on AIC- and BIC-criteria, dealing with the trade-oﬀ
between ﬁt and parsimony of the models, the correct model
is identiﬁed in 98% and 89% of the simulation runs, respec-
tively. Consequently, one needs to be cautious when modeling
both individual heterogeneity and unobserved age-group vari-
ability based on current status data as selecting the incorrect
model aﬀects parameter estimates. More speciﬁcally, reliable
estimates for the heterogeneity parameters σθi are of impor-
tance to derive relevant epidemiological parameters such as
the basic reproduction number (Coutinho et al., 1999).
6.2. Misspeciﬁcation of Individual Heterogeneity
Finally, we consider misspeciﬁcation of the bivariate indi-
vidual frailty distribution for θjk. To date, the popular but
restrictive shared frailty model is often considered to describe
bivariate time-to-event data. Therefore, correlated gamma-
lognormal current status data is generated, and shared
gamma, shared gamma-lognormal and DM shared gamma
frailty models are ﬁtted to the simulated data (see Table 5).
Although the estimates of the Gompertz baseline parameters
can be considered stable across the various models, the esti-
mated variance parameters σθi diﬀer substantially. Clearly, the
heterogeneity parameters σθi are underestimated when incor-
rectly assuming shared frailties instead of correlated frailties
with equal variances. However, this is in line with the neg-
ative correlation between ρθ and σθi which has been shown
before in the context of bivariate correlated frailty models
(Wienke et al., 2005). The shared frailty model, assuming
perfect correlation and common frailty variance, yields the
lowest variance estimate compared to the models accom-
modating overdispersion. In conclusion, misspecifying the
individual heterogeneity process has a substantial impact on
the estimation of both the frailty variances and overdisper-
sion parameters. The simulation-based Kendall’s τ estimates
for the shared gamma frailty model are in line with what we
expect theoretically, that is, τˆWS = τˆBS ≈ σˆ2θ1/(σˆ2θ1 + 2) = 0.226
(Wienke, 2010).
7. Discussion
Building upon the work by Hens et al. (2009) and
Molenberghs et al. (2010), we have studied parametric
overdispersed frailty models, combining gamma or inverse
Gaussian distributed individual frailty terms with lognor-
mally distributed stratum-speciﬁc random eﬀects, in the
context of current status data. Although the choice of
frailty distributions is merely inspired by the concepts of
partial marginalization and conjugacy through their closed-
form expressions for the Laplace transform, other frailty
distributions could be considered thereby increasing the
computational burden. Indeed, this leads to intractable
expressions for the likelihood function and, in combination
with lognormal random eﬀects, prevents partial marginaliza-
tion. Furthermore, (correlated) individual infection-speciﬁc
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Table 4
Averaged parameter estimates (Mean), relative bias (Rel. Bias) and empirical standard errors (Emp. s.e.) for the correlated
gamma, correlated Gompertz-gamma-lognormal and correlated Dirichlet-multinomial frailty model applied to 500 simulation
sets of size N = 3787 under the Gompertz-gamma-lognormal frailty model.
True Gamma- Dirichlet-
Parameter value Gamma lognormal multinomial
ξ1 × 102 0.600 Mean 0.598 0.613 0.611
Rel. Bias −0.004 0.021 0.019
Emp. s.e. 0.098 0.104 0.104
ν1 × 102 2.000 Mean 1.816 2.209 1.914
Rel. Bias −0.092 0.105 −0.043
Emp. s.e. 1.675 1.685 1.859
ξ2 × 102 0.200 Mean 0.190 0.196 0.194
Rel. Bias −0.050 −0.022 −0.031
Emp. s.e. 0.040 0.036 0.038
ν2 × 102 3.000 Mean 3.494 3.444 3.431
Rel. Bias 0.165 0.148 0.144
Emp. s.e. 1.398 1.019 1.321
σθ1 1.900 Mean 1.729 1.895 1.793
Rel. Bias −0.090 −0.003 −0.057
Emp. s.e. 0.692 0.641 0.723
σθ2 1.400 Mean 1.646 1.585 1.640
Rel. Bias 0.176 0.132 0.171
Emp. s.e. 0.583 0.422 0.563
ρθ 0.700 Mean 0.697 0.709 0.697
Rel. Bias −0.004 0.013 −0.004
Emp. s.e. 0.193 0.148 0.184
συ1 0.350 Mean − 0.351 −
Rel. Bias − 0.003 −
Emp. s.e. − 0.162 −
συ2 0.450 Mean − 0.491 −
Rel. Bias − 0.091 −
Emp. s.e. − 0.161 −
ρυ −0.600 Mean − −0.630 −
Rel. Bias − 0.051 −
Emp. s.e. − 0.240 −
ρ − Mean − − 0.104
Rel. Bias − − −
Emp. s.e. − − 0.017
τWS 0.321 Mean 0.300 0.322 −
Emp. s.e. 0.054 0.047 −
τBS 0.301 Mean 0.300 0.304 −
Emp. s.e. 0.054 0.043 −
CR − 0.930 0.980 0.920
AIC % − 0.000 0.982 0.018
BIC % − 0.018 0.892 0.089
frailties impose association between individual event times
whereas the lognormal random eﬀects capture overdisper-
sion at the stratum-level. Semi-parametric correlated frailty
models in which the hazard functions are left unspeci-
ﬁed cannot be considered due to well-known identiﬁability
issues (Iachine, 2004). However, since we are interested
in the estimation of the amount of unobserved hetero-
geneity and the strength of the association between event
times, a parametric choice with regard to the baseline
hazard function is a natural one. Particular attention
was given to the Gompertz distribution for (bivariate)
time-to-event outcomes, albeit that the presented method-
ology is generally applicable for all kinds of non-negative
distributions entailing parametric hazard functions (see Web
Appendices A and C).
Although attention is conﬁned to ML estimation includ-
ing partial marginalization regarding the gamma frailties,
pseudo-likelihood could be considered as an alternative for
which a large advantage in terms of computational stability
has been noticed before (Molenberghs et al., 2014). Perfor-
mance of the general model combining individual frailties
and overdispersion random eﬀects is evaluated and con-
trasted with the Dirichlet-multinomial frailty model. The
Dirichlet-multinomial model provides an easy way to accom-
modate overdispersion in multinomial response data. We
combined frailty methodology with the Dirichlet-multinomial
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Table 5
Averaged parameter estimates (Mean), relative bias (Rel. Bias) and empirical standard errors (Emp. s.e.) for the shared
gamma, shared gamma-lognormal and shared Dirichlet-multinomial frailty model applied to 500 simulation sets of size N =
3787 under the correlated gamma-lognormal frailty model.
True Gamma- Dirichlet-
Parameter value Gamma lognormal multinomial
ξ1 × 102 0.600 Mean 0.615 0.616 0.623
Rel. Bias 0.026 0.027 0.038
Emp. s.e. 0.069 0.069 0.069
ν1 × 102 2.000 Mean 0.854 0.980 0.845
Rel. Bias −0.573 −0.510 −0.578
Emp. s.e. 0.300 0.301 0.300
ξ2 × 102 0.200 Mean 0.219 0.215 0.223
Rel. Bias 0.094 0.074 0.117
Emp. s.e. 0.031 0.031 0.031
ν2 × 102 3.000 Mean 2.098 2.247 2.069
Rel. Bias −0.301 −0.251 −0.310
Emp. s.e. 0.330 0.333 0.326
σθ1 1.400 Mean 0.765 0.826 0.784
Rel. Bias −0.454 −0.410 −0.440
Emp. s.e. 0.060 0.059 0.059
σθ2 1.400 Mean 0.765 0.826 0.784
Rel. Bias −0.454 −0.410 −0.440
Emp. s.e. 0.060 0.059 0.059
ρθ 0.500 Mean 1.000 1.000 1.000
Rel. Bias − − −
Emp. s.e. − − −
συ1 0.350 Mean − 0.258 −
Rel. Bias − −0.262 −
Emp. s.e. − 0.057 −
συ2 0.450 Mean − 0.351 −
Rel. Bias − −0.221 −
Emp. s.e. − 0.071 −
ρυ −0.600 Mean − −0.679 −
Rel. Bias − 0.132 −
Emp. s.e. − 0.215 −
ρ − Mean − − 0.111
Rel. Bias − − −
Emp. s.e. − − 0.017
τWS 0.203 Mean 0.226 0.254 −
Emp. s.e. 0.032 0.031 −
τBS 0.183 Mean 0.226 0.225 −
Emp. s.e. 0.032 0.032 −
CR − 1.000 1.000 1.000
AIC % − 0.000 0.982 0.018
BIC % − 0.004 0.916 0.080
distribution to analyse bivariate current status data.
Although these models are quite simple in nature, they come
with the price of a reduced ﬂexibility as compared to the
combined (e.g., gamma-lognormal) frailty models. In addi-
tion, the Dirichlet-multinomial model has no straightforward
counterpart for the analysis of uncensored (or right-censored)
time-to-event data.
Since reliable estimates for (individual) heterogene-
ity parameters are quintessential in infectious disease
epidemiology when deriving important epidemiological
parameters such as the basic reproduction number R0
(Farrington et al., 2001), the correct assessment of both
individual heterogeneity and overdispersion is crucial. Our
simulation study reveals that one needs to be cautious when
modeling both individual heterogeneity and overdispersion,
notwithstanding they are acting at diﬀerent hierarchical lev-
els and playing distinct roles, since misspecifying one process
has large consequences with regard to the estimation of the
other. Although Dirichlet-multinomial frailty models could
outperform traditional bivariate frailty models, the perfor-
mance of models accommodating overdispersion by means of
introducing (log-)normal random eﬀects at the hazard level
should be investigated as well. Furthermore, large sample
sizes are required to infer parameters in the overdispersed
frailty models due to information loss in case of current sta-
tus data. Although model selection criteria such as AIC and
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BIC are used to perform model selection, a formal goodness-
of-ﬁt test would be very useful to assess whether the models
under investigation describe the data adequately. The devel-
opment of such a test is an interesting topic for further
research.
The analyses in this article rely on the assumption
of time-invariant individual heterogeneity. However, exten-
sions towards time-varying frailty models for single events
have been proposed by Farrington et al. (2012), and
discussed further by Unkel et al. (2014). Overdispersed
frailty models encompassing both the concepts of time-
varying individual frailties and overdispersion random eﬀects
at the age-group level provide an avenue for further research.
Furthermore, correlated frailties are constructed by means
of the “variable-in-common” method which is typically
used (Wienke, 2010). Nevertheless, in general, bivariate
distributions for θjk could be imposed implying diﬀerent
association structures among individual event times, albeit
potentially at the cost of tractable expressions for the
likelihood.
Finally, restricting the variance components in the hier-
archical frailty models to be non-negative implies a positive
intraclass correlation, meaning that two members of the
same cluster are more alike than those from diﬀerent groups.
Although such models prohibit negative dependence among
subjects in the same cluster, their induced marginal mod-
els do not, thereby being able to account for underdispersion
(Molenberghs and Verbeke, 2005, 2011). However, under-
dispersion seems unrealistic for the type of data presented
here, and is therefore considered beyond the scope of this
manuscript.
8. Supplementary Materials
Web Appendices A–E, referenced in Sections 3–7, are avail-
able with this article at the Biometrics website on Wiley
Online Library.
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